RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
Clinical trial NCT03412266 · UNKNOWN
Trial details
- NCT number
- NCT03412266
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2023-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.